The store will not work correctly when cookies are disabled.
4-((3,4-Dichlorophenyl)fluoromethylene)-1-((3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl)piperidine
ID: ALA3981959
PubChem CID: 86580865
Max Phase: Preclinical
Molecular Formula: C17H18Cl2FN3O2S
Molecular Weight: 418.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1n[nH]c(C)c1S(=O)(=O)N1CCC(=C(F)c2ccc(Cl)c(Cl)c2)CC1
Standard InChI: InChI=1S/C17H18Cl2FN3O2S/c1-10-17(11(2)22-21-10)26(24,25)23-7-5-12(6-8-23)16(20)13-3-4-14(18)15(19)9-13/h3-4,9H,5-8H2,1-2H3,(H,21,22)
Standard InChI Key: GYDNBJRNRTVGET-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
31.2472 -22.9226 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6600 -23.6325 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.0684 -22.9201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4541 -26.1249 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.4685 -25.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3609 -24.0555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0749 -23.6597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7818 -24.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7681 -24.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0509 -25.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3506 -24.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6277 -24.1578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9498 -24.9043 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7617 -24.8328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9443 -24.0363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2398 -23.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1582 -22.7931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2974 -25.4532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1868 -24.9158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2012 -24.0991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9169 -23.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6099 -24.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6020 -24.9319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8856 -25.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3232 -23.7215 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.9318 -22.8863 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
6 11 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
12 16 2 0
16 17 1 0
14 18 1 0
2 15 1 0
6 2 1 0
5 9 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
5 19 1 0
22 25 1 0
21 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 418.32 | Molecular Weight (Monoisotopic): 417.0481 | AlogP: 4.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.06 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.98 | CX Basic pKa: 2.62 | CX LogP: 2.96 | CX LogD: 2.96 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: -1.85 |
References
1. (2014) 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors, |